Endogenous heparinoids contribute to coagulopathy in patients with liver disease
- 29 February 2008
- journal article
- other
- Published by Elsevier BV in Journal of Hepatology
- Vol. 48 (2), 371-372
- https://doi.org/10.1016/j.jhep.2007.11.003
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Abnormalities of hemostasis in chronic liver disease: Reappraisal of their clinical significance and need for clinical and laboratory researchJournal of Hepatology, 2007
- The effects of glycosaminoglycans on coagulation: a thromboelastographic studyBlood Coagulation & Fibrinolysis, 2007
- 172 Heparinase I, II and III modified thromboelastography for the detection of different glycosaminoglycans' effect in cirrhotics with bacterial infectionJournal of Hepatology, 2006
- Endogenous heparinoids in acute variceal bleedingGut, 2005
- Endogenous heparin‐like activity detected by anti‐Xa assay in infected cirrhotic and non‐cirrhotic patientsScandinavian Journal of Gastroenterology, 2004
- Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective studyJournal of Hepatology, 2002
- Bacterial infection in the pathogenesis of variceal bleedingThe Lancet, 1999
- Plasma concentrations of endogenous heparinoids in portal hypertension.Gut, 1992